<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71296">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02177604</url>
  </required_header>
  <id_info>
    <org_study_id>140319</org_study_id>
    <nct_id>NCT02177604</nct_id>
  </id_info>
  <brief_title>Can Brief High-intensity Interval Training Mitigate the Adverse Consequences of High-fat Overfeeding?</brief_title>
  <acronym>GAINHIT</acronym>
  <official_title>Can Brief High-intensity Interval Training Mitigate the Adverse Consequences of High-fat Overfeeding?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Adelaide</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Adelaide Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of South Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Adelaide</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous research has shown that indulging in 50% more calories than required for as little
      as 3 days can significantly impact markers of metabolic health in lean and overweight
      individuals. Here, the investigators will determine if 3 brief sessions of high-intensity
      interval training can mitigate the adverse consequences of 7 days high-fat overfeeding in
      sedentary, overweight males.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in glucose metabolism</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in insulin and glucose area under the curve assessed via 75g Oral Glucose Tolerance Test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in plasma levels of cytokines</measure>
    <time_frame>1 week</time_frame>
    <description>Change in plasma levels of adiponectin, irisin, sex hormone-binding globulin and c-reactive protein</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in mitochondrial metabolism</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in citrate synthase activity, mitochondrial DNA content and protein levels of PGC-1a</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in resting energy expenditure</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in resting energy expenditure measured by metabolic cart</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in cognitive function</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in cognitive function, assessed by a series of computer tasks involving vigilant attention and speed processing.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Wingate HIT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7 days of high-fat overfeeding (50% excess calories) in conjunction 3 supervised sessions of Wingate High-intensity Interval Training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modified HIT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7 days of high-fat overfeeding (50% excess calories) in conjunction with 3 supervised sessions of Modified High-Intensity Interval Training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Exercise Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>7 days of high-fat overfeeding (50% excess calories) with no supervised exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wingate HIT</intervention_name>
    <description>3 sessions of Wingate based High-Intensity Interval Training (4 x 30 second &quot;all out&quot; sprints on a cycle ergometer interspersed by 3.5 minutes recovery)</description>
    <arm_group_label>Wingate HIT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Modified HIT</intervention_name>
    <description>3 sessions of Modified High-Intensity Interval Training (8 x 60 second sprints at approximately 90-95% VO2 peak on a cycle ergometer interspersed by 60 seconds recovery)</description>
    <arm_group_label>Modified HIT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-fat overfeeding</intervention_name>
    <description>7 days of high-fat overfeeding (50% excess calories)</description>
    <arm_group_label>Wingate HIT</arm_group_label>
    <arm_group_label>Modified HIT</arm_group_label>
    <arm_group_label>No Exercise Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sedentary (no more than 2 sessions of structured moderate intensity aerobic exercise
             or resistance training per week)

          -  Overweight (BMI 25-29.9 kg/m2)

        Exclusion Criteria:

          -  Personal history of any major illness (i.e. cardiovascular disease, diabetes,
             hypertension, cancer, renal/liver impairments, major psychiatric disorders, eating
             disorders etc.)

          -  History of chest pain (either at rest or during exercise.)

          -  Abnormal resting ECG at screening visit

          -  Chronic use of any prescribed or non-prescribed medications (i.e. anti-hypertensive,
             statins, metformin, anti-inflammatories, antidepressants etc.)

          -  Blood pressure or blood lipids outside of reference ranges

          -  Serum ferritin &lt;30ng/mL

          -  Uncontrolled asthma, current fever, or upper respiratory infection

          -  Current intake of &gt; 140g alcohol/week

          -  Current smokers of cigarettes/cigars/marijuana

          -  Current intake of any illicit substance

          -  Experience claustrophobia in confined spaces

          -  Donated blood in the past 3 months

          -  Migraines

          -  Unable to comprehend study protocol

          -  Unable to perform exercise on a cycle ergometer at second screening visit
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonie Heilbronn, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Adelaide</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leonie Heilbronn, PhD</last_name>
    <phone>61 8 8222 4900</phone>
    <email>leonie.heilbronn@adelaide.edu.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tom Butler</last_name>
    <email>thomas.butler@adelaide.edu.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>South Australian Health &amp; Medical Research Institute</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leonie Heilbronn</last_name>
      <phone>61 8 8222 4900</phone>
    </contact>
    <investigator>
      <last_name>Leonie Heilbronn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tom Butler, BHlthSci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 25, 2014</lastchanged_date>
  <firstreceived_date>June 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Adelaide</investigator_affiliation>
    <investigator_full_name>A/Prof Leonie Heilbronn</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
